{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:37:41Z","timestamp":1792031861216,"version":"4.4.0"},"reference-count":45,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Salix Pharmaceuticals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>In the palliative care population, prescription opioids are often considered viable pain relief options. However, in this complex patient population, the adverse effects of opioid medications should be identified and managed without delay. Common adverse effects can include constipation, nausea, somnolence, dizziness, vomiting, and pruritus. Less common adverse effects can include potentially lethal respiratory depression and cardiovascular effects. Critical aspects of safe opioid prescribing are recognition of side effects and knowledge of effective management strategies; prompt management is necessary for uninterrupted pain relief. Most complications are managed with general approaches such as dose reduction, opioid rotation, alternate routes of administration, and symptomatic management. The only opioid-induced complication for which US Food and Drug Administration-approved treatments currently exist is constipation. Treating laxative-refractory opioid-induced constipation (OIC) with peripherally acting mu-opioid receptor antagonists (PAMORAs), which block gastrointestinal opioid receptors, can restore gastrointestinal motility and fluid secretion. This narrative review discusses key complications of prescription opioid treatment and their management in the palliative care setting.<\/jats:p>","DOI":"10.3390\/jcm13102746","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T11:00:10Z","timestamp":1715079610000},"page":"2746","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Safe Management of Adverse Effects Associated with Prescription Opioids in the Palliative Care Population: A Narrative Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-2015","authenticated-orcid":false,"given":"Amanda","family":"Zimmerman","sequence":"first","affiliation":[{"name":"West Forsyth Pain Management, Winston Salem, NC 27103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Laitman","sequence":"additional","affiliation":[{"name":"Salix Pharmaceuticals, Bridgewater, NJ 08807, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for Prescribing Opioids for Pain\u2014United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm. Rep."},{"key":"ref_2","unstructured":"National Comprehensive Cancer Network (2023). NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain, National Comprehensive Cancer Network. Version 1."},{"key":"ref_3","unstructured":"National Comprehensive Cancer Network (2023). NCCN Clinical Practice Guidelines in Oncology: Palliative Care, National Comprehensive Cancer Network. Version 1."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmjspcare-2021-003178","article-title":"Opioid safety recommendations in adult palliative medicine: A North American Delphi expert consensus","volume":"12","author":"Lau","year":"2022","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_5","unstructured":"McDonagh, M.S., Selph, S.S., Buckley, D.I., Holmes, R.S., Mauer, K., Ramirez, S., Hsu, F.C., Dana, T., Fu, R., and Chou, R. (2023, May 10). Nonopioid Pharmacologic Treatments for Chronic Pain. Comparative Effectiveness Review Number 228. (Prepared by the Pacific Northwest Evidence-Based Practice Center under Contract No. 290-2015-00009-I.) AHRQ Publication No. 20-EHC010, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556277\/pdf\/Bookshelf_NBK556277.pdf."},{"key":"ref_6","unstructured":"(2024, April 03). Palliative Care. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/palliative-care."},{"key":"ref_7","unstructured":"(2024, April 03). Palliative Care. Available online: https:\/\/www.cancer.org\/cancer\/managing-cancer\/palliative-care.html."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kernick, L., Glare, P., Hosie, A., Chiu, A., and Kissane, D.W. (2023). Prevalence and management of chronic nonmalignant pain in palliative care populations: A systematic review. Palliat. Support. Care, 1\u20137.","DOI":"10.1017\/S1478951523000378"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hagarty, A.M., Bush, S.H., Talarico, R., Lapenskie, J., and Tanuseputro, P. (2020). Severe pain at the end of life: A population-level observational study. BMC Palliat. Care, 19.","DOI":"10.1186\/s12904-020-00569-2"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/phar.1986","article-title":"Review of opioid pharmacogenetics and considerations for pain management","volume":"37","author":"Hamadeh","year":"2017","journal-title":"Pharmacotherapy"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Paul, A.K., Smith, C.M., Rahmatullah, M., Nissapatorn, V., Wilairatana, P., Spetea, M., Gueven, N., and Dietis, N. (2021). Opioid analgesia and opioid-induced adverse effects: A review. Pharmaceuticals, 14.","DOI":"10.3390\/ph14111091"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tips.2011.06.008","article-title":"The delta opioid receptor: An evolving target for the treatment of brain disorders","volume":"32","author":"Pradhan","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jpainsymman.2019.02.009","article-title":"The burden of opioid adverse events and the influence on cancer patients\u2019 symptomatology","volume":"57","author":"Corli","year":"2019","journal-title":"J. Pain Symptom Manag."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1097\/PRS.0000000000000681","article-title":"Clinical consequences of inadequate pain relief: Barriers to optimal pain management","volume":"134","author":"Baratta","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.14694\/EdBook_AM.2015.35.e593","article-title":"Cancer pain management: Safe and effective use of opioids","volume":"35","author":"Bruera","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.2174\/1381612825666190717152226","article-title":"Opioid analgesics adverse effects: The other side of the coin","volume":"25","author":"Mercadante","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/psb.1755","article-title":"Opioid use in palliative care: New developments and guidelines","volume":"30","author":"Gishen","year":"2019","journal-title":"Prescriber"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"ref_19","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/J354v21n01_05","article-title":"Adverse effects of opioids on the central nervous systems of palliative care patients","volume":"21","author":"Macleod","year":"2007","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/clinem\/dgz022","article-title":"Opioids and their endocrine effects: A systematic review and meta-analysis","volume":"105","author":"Bruin","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/pme.12912","article-title":"Cognitive effects and sedation","volume":"16","author":"Dhingra","year":"2015","journal-title":"Pain Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2049463712438299","article-title":"Opioids and endocrine dysfunction","volume":"6","author":"Seyfried","year":"2012","journal-title":"Br. J. Pain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2468-1253(18)30008-6","article-title":"Pathophysiology, diagnosis, and management of opioid-induced constipation","volume":"3","author":"Farmer","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s10620-018-5394-8","article-title":"Significant morbidity and mortality associated with fecal impaction in patients who present to the emergency department","volume":"64","author":"Sommers","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijscr.2017.11.060","article-title":"Opioid drugs and stercoral perforation of the colon: Case report and review of literature","volume":"42","author":"Poitras","year":"2018","journal-title":"Int. J. Surg. Case Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American Gastroenterological Association Institute guideline on the medical management of opioid-induced constipation","volume":"156","author":"Crockett","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, version 3.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Swarm","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s40122-021-00271-y","article-title":"Impact and consequences of opioid-induced constipation: A survey of patients","volume":"10","author":"Varrassi","year":"2021","journal-title":"Pain Ther."},{"key":"ref_31","unstructured":"(2020). Relistor [Package Insert], Salix Pharmaceuticals."},{"key":"ref_32","unstructured":"(2020). Movantik [Package Insert], AstraZeneca Pharmaceuticals."},{"key":"ref_33","unstructured":"(2020). Symproic [Package Insert], Shionogi & Co., Ltd."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1526-4637.2009.00583.x","article-title":"Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: Mechanisms, implications, and management options","volume":"10","author":"Porreca","year":"2009","journal-title":"Pain Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2015.02.023","article-title":"Promethazine use among chronic pain patients","volume":"150","author":"Lynch","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s40263-019-00660-0","article-title":"Opioid-induced tolerance and hyperalgesia","volume":"33","author":"Mercadante","year":"2019","journal-title":"CNS Drugs"},{"key":"ref_38","unstructured":"(2023, May 25). Benzodiazepines and Opioids, Available online: https:\/\/nida.nih.gov\/research-topics\/opioids\/benzodiazepines-opioids."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1526-5900(03)00556-X","article-title":"Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review","volume":"4","author":"McNicol","year":"2003","journal-title":"J. Pain"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.21037\/apm.2019.12.09","article-title":"Combining opioids and benzodiazepines: Effects on mortality and severe adverse respiratory events","volume":"9","author":"Boon","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"ref_41","unstructured":"(2023, June 20). FDA Approves First Over-the-Counter Naloxone Nasal Spray [Press Release], Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-over-counter-naloxone-nasal-spray."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/DDDT.S342409","article-title":"Less well-known consequences of the long-term use of opioid analgesics: A comprehensive literature review","volume":"16","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s11606-020-06155-9","article-title":"The association between prescribed opioid receipt and community-acquired pneumonia in adults: A systematic review and meta-analysis","volume":"35","author":"Steffens","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/pme.12915","article-title":"Cardiac effects of opioid therapy","volume":"16","author":"Chen","year":"2015","journal-title":"Pain Med."},{"key":"ref_45","first-page":"229","article-title":"Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?","volume":"4","author":"Mujtaba","year":"2013","journal-title":"J. Cardiovasc. Dis. Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/10\/2746\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:41:08Z","timestamp":1760107268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/10\/2746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["jcm13102746"],"URL":"https:\/\/doi.org\/10.3390\/jcm13102746","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]}}}